Ongoing Research
TRIPLEX Study -recruiting
A randomized phase III trial investigating the survival benefit of adding thoracic radiotherapy to durvalumab (MEDI4736) immunotherapy plus chemotherapy in extensive-stage small-cell lung cancer.
Lead Researcher: Bjørn Henning Grønberg
ACHILES Study
A randomized phase II study comparing atezolizumab after concurrent chemoradiotherapy with chemoradiotherapy alone in limited-disease small-cell lung cancer.
Lead Researcher: Bjørn Henning Grønberg